Cargando…
Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Scientific and Technological Research Council of Turkey (TUBITAK)
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388104/ https://www.ncbi.nlm.nih.gov/pubmed/36326374 http://dx.doi.org/10.55730/1300-0144.5448 |
_version_ | 1785082036879360000 |
---|---|
author | VELİOĞLU, Arzu ALAGÖZ, Selma BARUTÇU ATAŞ, Dilek ARIKAN, Hakkı AŞICIOĞLU, Ebru AKSU, Burak SEYAHİ, Nurhan TUĞLULAR, Serhan |
author_facet | VELİOĞLU, Arzu ALAGÖZ, Selma BARUTÇU ATAŞ, Dilek ARIKAN, Hakkı AŞICIOĞLU, Ebru AKSU, Burak SEYAHİ, Nurhan TUĞLULAR, Serhan |
author_sort | VELİOĞLU, Arzu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10388104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Scientific and Technological Research Council of Turkey (TUBITAK) |
record_format | MEDLINE/PubMed |
spelling | pubmed-103881042023-08-01 Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk VELİOĞLU, Arzu ALAGÖZ, Selma BARUTÇU ATAŞ, Dilek ARIKAN, Hakkı AŞICIOĞLU, Ebru AKSU, Burak SEYAHİ, Nurhan TUĞLULAR, Serhan Turk J Med Sci Letter to the Editor Scientific and Technological Research Council of Turkey (TUBITAK) 2022-04-19 /pmc/articles/PMC10388104/ /pubmed/36326374 http://dx.doi.org/10.55730/1300-0144.5448 Text en © TÜBİTAK https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
spellingShingle | Letter to the Editor VELİOĞLU, Arzu ALAGÖZ, Selma BARUTÇU ATAŞ, Dilek ARIKAN, Hakkı AŞICIOĞLU, Ebru AKSU, Burak SEYAHİ, Nurhan TUĞLULAR, Serhan Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title | Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title_full | Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title_fullStr | Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title_full_unstemmed | Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title_short | Low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
title_sort | low-dose valacyclovir use with preemptive monitoring in kidney transplant recipients with intermediate cytomegalovirus infection risk |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388104/ https://www.ncbi.nlm.nih.gov/pubmed/36326374 http://dx.doi.org/10.55730/1300-0144.5448 |
work_keys_str_mv | AT veliogluarzu lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT alagozselma lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT barutcuatasdilek lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT arikanhakkı lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT asiciogluebru lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT aksuburak lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT seyahinurhan lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk AT tuglularserhan lowdosevalacyclovirusewithpreemptivemonitoringinkidneytransplantrecipientswithintermediatecytomegalovirusinfectionrisk |